Region’s breast cancer sufferers offered hope

New research has revealed a new cancer treatment helps reduce the relapse rate of breast cancer in older women.

  • E-Mail
By  Stuart Qualtrough Published  April 25, 2005

New research has revealed a new cancer treatment helps reduce the relapse rate of breast cancer in older women. The study shows a reduction of nearly 20% in the rate of relapses among post-menopausal women using the new drug Femara, if taken immediately after undergoing surgery to remove breast tumours. The research was conducted by medics at the Medical Oncology Department Centre at the Boulloche Hospital in France. The study results are currently being shared with doctors across the Middle East in a series of congresses and seminars. “This is very good news for post—menopausal women in the UAE who are surviving breast cancer and for women around the world,” said Dr Farid Khalifa, Dubai Hospital’s head of oncology. “We will be using this treatment immediately.” Breast cancer, however, accounts for almost 40% of all female cancers throughout the Middle East, with 800,000 women across the world diagnosed with the disease each year. Research data from clinical trials involving 8000 post-menopausal women with cancer, showed a 19% reduction in relapse risk and a 27% reduction in metastases, the migration of the cancer to other parts of the body. The study also showed that the treatment, produced by Novartis, is less likely to produce the same kind of side effects seen in other common treatments.

Add a Comment

Your display name This field is mandatory

Your e-mail address This field is mandatory (Your e-mail address won't be published)

Security code